BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4046498)

  • 21. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.
    Castellot JJ; Beeler DL; Rosenberg RD; Karnovsky MJ
    J Cell Physiol; 1984 Sep; 120(3):315-20. PubMed ID: 6746751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
    Majack RA; Clowes AW
    J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terminally alkylated heparin. 2. Potent antiproliferative agent for vascular smooth muscle cells.
    Gohda M; Magoshi T; Kato S; Noguchi T; Yasuda S; Nonogi H; Matsuda T
    Biomacromolecules; 2001; 2(4):1178-83. PubMed ID: 11777390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin.
    Williams SP; Mason RM
    Arch Biochem Biophys; 1991 Jun; 287(2):386-96. PubMed ID: 1716868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
    Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
    J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis.
    Chan P; Patel M; Betteridge L; Munro E; Schachter M; Wolfe J; Sever P
    Lancet; 1993 Feb; 341(8841):341-2. PubMed ID: 8094116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.
    Castellot JJ; Choay J; Lormeau JC; Petitou M; Sache E; Karnovsky MJ
    J Cell Biol; 1986 May; 102(5):1979-84. PubMed ID: 3700480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of ligustrazine and heparin on growth and cleavage of primary cultural vascular smooth muscle].
    Tang LL; Wang LH; Zhu GY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Jan; 15(1):38-9. PubMed ID: 7767067
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation.
    Joseph PA; Garg HG; Thompson BT; Liu X; Hales CA
    Biochem Biophys Res Commun; 1997 Dec; 241(1):18-23. PubMed ID: 9405227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
    Orlandi A; Ropraz P; Gabbiani G
    Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin.
    Underwood PA; Mitchell SM
    Cardiovasc Res; 2000 Sep; 47(4):749-58. PubMed ID: 10974223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin inhibits SMC growth in the presence of human and fetal bovine serum.
    Cindhuchao N; Quinn DA; Garg HG; Hales CA
    Biochem Biophys Res Commun; 2003 Feb; 302(1):84-8. PubMed ID: 12593851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle.
    Newcomb PM; Herman IM
    J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.
    Delmolino LM; Castellot JJ
    J Cell Physiol; 1997 Dec; 173(3):371-9. PubMed ID: 9369950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro.
    Fager G; Hansson GK; Ottosson P; Dahllöf B; Bondjers G
    Exp Cell Res; 1988 Jun; 176(2):319-35. PubMed ID: 2837401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
    Segev A; Aviezer D; Safran M; Gross Z; Yayon A
    Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture.
    Wang Y; Kovanen PT
    Circ Res; 1999 Jan 8-22; 84(1):74-83. PubMed ID: 9915776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis.
    Cochran DL; Castellot JJ; Karnovsky MJ
    J Cell Physiol; 1985 Jul; 124(1):29-36. PubMed ID: 2413048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro.
    Nicosia RF; Villaschi S
    Lab Invest; 1995 Nov; 73(5):658-66. PubMed ID: 7474939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
    Hämmerle H; Betz E; Herr D
    Vasa; 1991; 20(3):207-15. PubMed ID: 1659056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.